Position in LNTH
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$52,154,990
New position
Shares Held
687,607
first reported quarter
Ownership
1.06%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 91.01972493008361.ToString("F0")%
Shared 0.ToString("F0")%
None 8.980275069916392.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026BROWN ADVISORY INC holds $557,338,297 across 8 Drug Manufacturers - Specialty & Generic names. LNTH ranks #2 (9.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
4,188,438 | $495,115,253 | |
| 2 | LNTH |
Lantheus Holdings, Inc.
This page
|
687,607 | $52,154,990 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
34,552 | $4,551,880 | |
| 4 | ANIP |
Ani Pharmaceuticals Inc
|
47,250 | $3,633,525 | |
| 5 | HLN |
Haleon plc
|
79,376 | $794,553 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
26,610 | $636,777 | |
| 7 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
19,930 | $277,027 | |
| 8 | VTRS |
Viatris Inc
|
12,901 | $174,292 |
All Filings in LNTH
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $52,154,990 | 687,607 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||